Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Hesje CK, Drlica K, Blondeau JM (2014)  Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy dku389.

  View at Publisher | View at Google Scholar
• Nagappan V, Deresinski S (2007) Posaconazole: a broad-spectrum triazole antifungal agent. Clinical infectious diseases. 45:1610-1617.
  View at Publisher | View at Google Scholar

• Indicate VF. Comparative Mutant Prevention.

  View at Publisher | View at Google Scholar
• Andes DR, Diekema DJ, Pfaller MA, Marchillo K, Bohrmueller J (2008) In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Antimicrobial agents and chemotherapy. 52: 3497-3503.
  View at Publisher | View at Google Scholar

• Barrett JF (2005) MRSA–what is it, and how do we deal with the problem?. Expert opinion on therapeutic targets 9: 253-65.

  View at Publisher | View at Google Scholar
• Butler MS, Newman DJ (2008) Mother Nature’s gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery. InNatural Compounds as Drugs Volume I 2008 (pp. 1-44). Birkhäuser Basel.
  View at Publisher | View at Google Scholar

• Mazumdar K, Kumar KA, Dutta NK (2010) Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future. International journal of antimicrobial agents 36: 295-302.

  View at Publisher | View at Google Scholar
• Almirante B, Rodriguez D (2007) Antifungal agents in neonates. Pediatric Drugs. 9:311-321.
  View at Publisher | View at Google Scholar

• Helaly GF, El-Aziz AA, Sonbol FI, El-Banna TE, Louise NL (2011) Dexpanthenol and propolis extract in combination with local antibiotics for treatment of Staphylococcal and Pseudomonal wound infections. Archives of Clinical Microbiology 2.

  View at Publisher | View at Google Scholar
• Parish CA, Smith SK, Calati K, Zink D, Wilson K, et al. (2008) Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation. Journal of the American Chemical Society. 130:7060-7066.
  View at Publisher | View at Google Scholar
• Lipp HP (2008) Antifungal agents–clinical pharmacokinetics and drug interactions. Mycoses. 51(s1):7-18.
  View at Publisher | View at Google Scholar
• Kauffman CA, Carver PL (2008) Update on echinocandin antifungals. InSeminars in Respiratory and critical care medicine pp. 211-219. © Thieme Medical Publishers.
  View at Publisher | View at Google Scholar
• Malani AN, Kauffman CA (2007) Candida urinary tract infections: treatment options. Expert review of anti-infective therapy. 5:277-284.
  View at Publisher | View at Google Scholar
• Misiek M, Hoffmeister D (2007) Fungal genetics, genomics, and secondary metabolites in pharmaceutical sciences. Planta medica. 73:103-115.
  View at Publisher | View at Google Scholar
• Stelzmueller I, Lass‐Floerl C, Geltner C, Graziadei I, Schneeberger S, et al. (2008) Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transplant International. 21: 534-546.
  View at Publisher | View at Google Scholar
• Brielmaier BD, Casabar E, Kurtzeborn CM, Mckinnon PS, Ritchie DJ (2008) Early clinical experience with anidulafungin at a large tertiary care medical center. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 28:64-73.
  View at Publisher | View at Google Scholar
• Forrest G (2006) Role of antifungal susceptibility testing in patient management. Current opinion in infectious diseases. 19:538-543.
  View at Publisher | View at Google Scholar
• Damle B, Stogniew M, Dowell J (2008) Pharmacokinetics and tissue distribution of anidulafungin in rats. Antimicrobial agents and chemotherapy. 2008 Jul 1;52(7):2673-6.
  View at Publisher | View at Google Scholar
• Grover ND (2010) Echinocandins: A ray of hope in antifungal drug therapy. Indian journal of pharmacology. 42:422.
  View at Publisher | View at Google Scholar
• Zaoutis T, Walsh TJ (2007) Antifungal therapy for neonatal candidiasis. Current opinion in infectious diseases. 20:592-597.
  View at Publisher | View at Google Scholar
• Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ (2007) Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. International journal of antimicrobial agents. 29:557-562.
  View at Publisher | View at Google Scholar
• Glöckner A (2011) Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin-review of the literature. European journal of medical research. 16:167.
  View at Publisher | View at Google Scholar
• Perkhofer S, Jost D, Dierich MP, Lass-Flörl C (2008) Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrobial agents and chemotherapy. 52:1873-1875.
  View at Publisher | View at Google Scholar
• Dangi YS, Soni ML, Namdeo KP (2010) Oral candidiasis: A review. Int J Pharm Pharm Sci. 2:36-41.
  View at Publisher | View at Google Scholar
• Arnold TM, Dotson E, Sarosi GA, Hage CA (2010) Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society. 7:222-228.
  View at Publisher | View at Google Scholar
• Sallam A, Lynn W, McCluskey P, Lightman S (2006) Endogenous candida endophthalmitis. Expert review of anti-infective therapy. 4:675-685.
  View at Publisher | View at Google Scholar

• Ngondi JL, Oben JE and Minka SR, 2005. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids in health and disease, 4(1), p.12.

  View at Publisher | View at Google Scholar
• Castelli MV, Butassi E, Monteiro MC, Svetaz LA, Vicente F, et al. (2014) Novel antifungal agents: a patent review (2011–present). Expert opinion on therapeutic patents. 24:323-338.
  View at Publisher | View at Google Scholar

• Saeidnia S and Abdollahi M, 2013. Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicology and applied pharmacology, 273(3), pp.442-455.

  View at Publisher | View at Google Scholar
• Lepak A, Castanheira M, Diekema D, Pfaller M, Andes D (2012) Optimizing echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations. Antimicrobial agents and chemotherapy. 56: 5875-5882.
  View at Publisher | View at Google Scholar

• Salari P, Rezaie A, Larijani B and Abdollahi M, 2008. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Medical Science Monitor, 14(3), pp.RA37-RA44.

  View at Publisher | View at Google Scholar

• Kaneria M, Baravalia Y and Vaghasiya Y, 2009. Determination of antibacterial and antioxidant potential of some medicinal plants from Saurashtra region, India. Indian journal of pharmaceutical sciences, 71(4), p.406.

  View at Publisher | View at Google Scholar
• Brown JW (2009) Fungal infections after hematopoietic cell transplantation. Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. 1346-66.
  View at Publisher | View at Google Scholar
• Jacobsen MD, Whyte JA, Odds FC (2007) Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro. Antimicrobial agents and chemotherapy. 51:1882-4.
  View at Publisher | View at Google Scholar

• Ranjbar A, Khorami S, Safarabadi M, Shahmoradi A, Malekirad AA, et al. 2006. Antioxidant activity of Iranian Echium amoenum fisch & CA Mey flower decoction in humans: A cross-sectional before/after clinical trial. Evidence-based Complementary and Alternative Medicine, 3(4), pp.469-473.

  View at Publisher | View at Google Scholar
• Moudgal V, Sobel J (2010) Antifungals to treat Candida albicans. Expert opinion on pharmacotherapy. 11:2037-2048.
  View at Publisher | View at Google Scholar

• Schang LM, St. Vincent MR, Lacasse JJ (2006)  Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs. Antiviral Chemistry and Chemotherapy 17: 293-320.

  View at Publisher | View at Google Scholar

• Dehghan G, Shafiee A, Ghahremani MH, Ardestani SK and Abdollahi M, 2007. Antioxidant potential of various extracts from Ferula szovitsiana. in relation to their phenolic content. Pharmaceutical Biology, 45(9), pp.691-699.

  View at Publisher | View at Google Scholar

• Schang LM (2005)  Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs. Current Drug Targets-Infectious Disorders 5: 29-37.

  View at Publisher | View at Google Scholar
• Batova M, Klobucnikova V, Oblasova Z, Gregan J, Zahradnik P, Hapala I, Subik J, Schüller C (2010) Chemogenomic and transcriptome analysis identifies mode of action of the chemosensitizing agent CTBT (7-chlorotetrazolo [5, 1-c] benzo [1, 2, 4] triazine). BMC genomics. 11:153.
  View at Publisher | View at Google Scholar

• Jia P, Xu YJ, Zhang ZL, Li K, Li B, et al. 2012. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. Journal of Orthopaedic Research, 30(11), pp.1843-1852.

  View at Publisher | View at Google Scholar

• Schang LM (2006)  Herpes simplex viruses in antiviral drug discovery. Current pharmaceutical design 12: 1357-1370.

  View at Publisher | View at Google Scholar

• Mehdipour S, Yasa N, Dehghan G, Khorasani R, Mohammadirad A, et al. 2006. Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to α‐tocopherol. Phytotherapy Research, 20(7), pp.591-594.

  View at Publisher | View at Google Scholar
• Minnebruggen GV, François IE, Cammue BP, Thevissen K, Vroome V, (2014). A general overview on past, present and future antimycotics. The Open Mycology Journal. 4(1).
  View at Publisher | View at Google Scholar

• Hasani-Ranjbar S, Nayebi N, Larijani B and Abdollahi M, 2010. A systematic review of the efficacy and safety of Teucrium species; from anti-oxidant to anti-diabetic effects. IJP-International Journal of Pharmacology, 6(4), pp.315-325.

  View at Publisher | View at Google Scholar

• Schang LM (2005) Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science. Expert review of anti-infective therapy 3: 145-149.

  View at Publisher | View at Google Scholar
• Seyedmousavi S, Meletiadis J, Melchers WJ, Rijs AJ, Mouton JW, et al. (2013) In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus. Antimicrobial agents and chemotherapy. 57:796-803.

   

  View at Publisher | View at Google Scholar

• Sharif PS, Asalforoush M, Ameri F, Larijani B and Abdollahi M, 2010. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age, 32(2), pp.179-186.

  View at Publisher | View at Google Scholar

• Schang LM (2006) Pharmacological Cyclin-Dependent Kinase Inhibitors (PCIs) as Potential Antiviral Drugs. Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Infective Agents) 5: 345-355.

  View at Publisher | View at Google Scholar

• Yousefzadeh G, Larijani B, Mohammadirad A, Heshmat R, Dehghan G, et al. 2006. Determination of Oxidative Stress Status and Concentration of TGF‐β1 in the Blood and Saliva of Osteoporotic Subjects. Annals of the New York Academy of Sciences, 1091(1), pp.142-150.

  View at Publisher | View at Google Scholar